Startek - SRT Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Startek in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SRT shares.
View SRT analyst ratings or view top-rated stocks.

2 Wall Street analysts have issued 1-year price objectives for Startek's stock. Their SRT share price forecasts range from $5.50 to $8.00. On average, they anticipate the company's share price to reach $6.50 in the next year. This suggests a possible upside of 60.5% from the stock's current price.
View analysts price targets for SRT or view top-rated stocks among Wall Street analysts.

Startek's stock was trading at $5.22 at the beginning of 2022. Since then, SRT stock has decreased by 22.4% and is now trading at $4.05.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our SRT earnings forecast.

Startek, Inc. (NYSE:SRT) posted its quarterly earnings data on Tuesday, November, 2nd. The business services provider reported $0.07 EPS for the quarter, topping the consensus estimate of $0.04 by $0.03. The business services provider earned $172.79 million during the quarter, compared to analysts' expectations of $162.31 million. Startek had a trailing twelve-month return on equity of 4.12% and a net margin of 1.08%. During the same quarter last year, the company posted $0.01 earnings per share.

Based on aggregate information from My MarketBeat watchlists, some companies that other Startek investors own include Amicus Therapeutics (FOLD), KeyCorp (KEY), SentinelOne (S), Vishay Intertechnology (VSH), Huntington Bancshares (HBAN), Kindred Biosciences (KIN), Mitek Systems (MITK), People's United Financial (PBCT), Pfizer (PFE) and

Startek trades on the New York Stock Exchange (NYSE) under the ticker symbol "SRT."

Startek's stock is owned by a variety of retail and institutional investors. Top institutional investors include Millennium Management LLC (0.32%), Citadel Advisors LLC (0.15%), State Street Corp (0.14%), Northern Trust Corp (0.07%), Los Angeles Capital Management LLC (0.05%) and Gladius Capital Management LP (0.04%). Insiders that own company stock include Albert Aboody, Aparup Sengupta, Csp Management Ltd and Mukesh Sharda.
View institutional ownership trends.

Shares of SRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SRT stock can currently be purchased for approximately $4.05.

Startek (NYSE:SRT) has a market capitalization of $163.36 million and generates $703.63 million in revenue each year. The business services provider earns $1.50 million in net income (profit) each year or $0.18 on an earnings per share basis.

The company employs 45,000 workers across the globe.

Startek's mailing address is 6200 SOUTH SYRACUSE WAY SUITE 485, GREENWOOD VILLAGE CO, 80111. The official website for the company is www.startek.com. The business services provider can be reached via phone at (303) 262-4500, via email at investor@startek.com, or via fax at 302-655-5049.